ASP Isotopes Inc. (ASPI)
| Market Cap | 668.55M |
| Revenue (ttm) | 23.85M |
| Net Income (ttm) | -175.09M |
| Shares Out | 125.90M |
| EPS (ttm) | -2.11 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,075,598 |
| Open | 5.53 |
| Previous Close | 5.65 |
| Day's Range | 5.16 - 5.53 |
| 52-Week Range | 3.92 - 14.49 |
| Beta | 3.61 |
| Analysts | Strong Buy |
| Price Target | 12.00 (+125.99%) |
| Earnings Date | Apr 10, 2026 |
About ASPI
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages... [Read more]
Financial Performance
In 2025, ASP Isotopes's revenue was $23.85 million, an increase of 475.51% compared to the previous year's $4.14 million. Losses were -$175.09 million, 398.6% more than in 2024.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for ASPI stock is "Strong Buy." The 12-month stock price target is $12.0, which is an increase of 125.99% from the latest price.
News
ASP Isotopes Earnings Call Transcript: Q4 2025
Transitioning to commercial operations, revenue surged 480% in 2025, with major product launches and U.S. expansion planned for 2026. EBITDA is targeted to exceed $300 million by 2031, driven by strong demand in isotopes, helium, and electronic gases.
ASP Isotopes Inc. Provides Business Update
First Commercial Shipments Expected Across Multiple Isotopes in 2026 Expect to Obtain Helium Phase 1 Nameplate Capacity in Q3 2026 EBITDA Target of Greater Than $300 Million in 2031 Cash, Cash Equival...
ASP Isotopes to Host Business Update Conference Call on April 13, 2026, at 8:00 AM ET
DALLAS, April 10, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the pr...
Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
ASP Isotopes Announces Strategic Collaboration Between Quantum Leap Energy and University of Bristol to Design Advanced Laser Research Facility
Collaboration to develop a cutting-edge lithium laser enrichment research facility in the UK Collaboration to develop a cutting-edge lithium laser enrichment research facility in the UK
Why ASP Isotopes Stock Is Surging Today
The drilling program reached the required cumulative nameplate flow rate, reducing execution risk as remaining work shifts primarily to engineering tasks.
ASP Isotopes Completes Well Drilling Required for Phase 1 of Renergen Helium Project Four Months Ahead of Schedule
DALLAS, March 23, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the pr...
ASP Isotopes Transcript: 2nd Annual CG Virtual Sustainability Summit
Helium supply disruptions are driving urgent expansion of South African production, with phase I ahead of schedule and phase II backed by $0.5B in U.S. funding. Commercialization of Silicon-28, Carbon-14, and Ytterbium-176 is expected by H1 2026, while regulatory and commercial milestones support growth in uranium enrichment and electronic gases.
ASP Isotopes to Participate in Canaccord Genuity's 2nd Annual CG Virtual Sustainability Summit
DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the pr...
What's Going On With ASP Isotopes Stock?
Shares of ASP Isotopes Inc. (NASDAQ:ASPI) are rising today after announcing that it had entered into a non-binding memorandum of understanding with a large publicly traded U.S. energy company that ope...
Quantum Leap Energy Enters into Memorandum of Understanding with a Large U.S. Energy Company Regarding Evaluation of Support to Advance Domestic Enriched Uranium Fuel Supply Chain
Marks an important step toward enhancing the domestic supply chain for nuclear fuel in the United States Advances QLE's strategy to build U.S.-based capabilities to support advanced nuclear fuel produ...
ASP Isotopes Transcript: Emerging Growth Virtual Conference
ASP Isotopes detailed expansion plans across nuclear medicine, semiconductors, and nuclear fuels, highlighting new contracts, plant upgrades, and a pending spin-off. Regulatory progress and strategic supply chain moves position the company for significant growth in 2024.
ASP Isotopes Announces Quantum Leap Energy and Necsa Advance Strategic Collaboration Aimed at Production of HALEU Nuclear Fuel
Agreement between QLE's South African subsidiary and Necsa related to the siting, design, construction, commission and operation of an enrichment facility on the Necsa site in Pelindaba, with QLE's ob...
ASP Isotopes Announces Establishment of Quantum Leap Energy Strategic Advisory Board, Bolstering its Plans for the Nuclear Fuel Sector
Distinguished Nuclear Fuel and Advanced Materials Leaders Appointed as Initial SAB Members Distinguished Nuclear Fuel and Advanced Materials Leaders Appointed as Initial SAB Members
Halper Sadeh LLC Encourages ASP Isotopes Inc. Shareholders To Contact The Firm To Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is invest...
ASP Isotopes Inc. Provides Production Update on the Renergen Helium Project
This Production Update reports operational progress since April 2025, following bridge loan funding provided by ASP Isotopes Inc. (“ASPI”) (prior to the completion of ASPI's acquisition of Renergen), ...
ASP Isotopes Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ASP Isotopes, Inc. - ASPI
NEW YORK and NEW ORLEANS, Jan. 16, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Halper Sadeh LLC Encourages ASP Isotopes Inc. Shareholders to Contact the Firm to Discuss Their Rights
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of ASP Isotopes Inc. (NASDAQ: ASPI) breached their fiduciary duties to...
ASP Isotopes Closes Acquisition of Renergen
Combined Company Expected to Become a Global Critical Materials Provider Focused on High-Growth Industries in Isotope and Helium Markets Renergen Expected to Benefit from $750 million of Committed Deb...
ASP Isotopes Inc. Announces Receipt of Regulatory Approvals for Acquisition of Renergen Limited
Positive progress in operations at Renergen's Virginia Gas Project with a production update expected at the end of January 2026 Positive progress in operations at Renergen's Virginia Gas Project with ...
ASP Isotopes Inc. Announces Paul Mann to Return from Temporary Leave of Absence as Executive Chairman and Chief Executive Officer
WASHINGTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes f...
ASP Isotopes Announces Endowment of New Photonics Chair at Wits University to Advance Photonics Research
WASHINGTON, Nov. 28, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the prod...
ASP Isotopes Earnings Call Transcript: Q3 2025
Operational enrichment plants are producing commercial samples, with revenue growth in radiopharmaceuticals and major acquisitions advancing vertical integration. Cash position is strong, with new plant construction and IPO plans for Quantum Leap Energy underway.
ASP Isotopes to Provide Quarterly Business Update Call on November 21, 2025 at 8:30am EST
WASHINGTON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the...
Quantum Leap Energy LLC Announces Private Placement of Convertible Notes Led by American Ventures LLC
WASHINGTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Quantum Leap Energy LLC (“QLE”), a wholly-owned subsidiary of ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or “ASPI” or the “Company”), an advanced mate...